Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2010-03-04 Regulatory Filings
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-03-04 English
Regulatory Filings 2010
Regulatory Filings
2010-03-04 English
Regulatory Filings 2010
Regulatory Filings
2010-03-04 English
POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
Regulatory Filings Classification · 95% confidence The document is titled 'Post Effective Amendment No. 1 to Form S-3' and is filed with the SEC. It discusses the removal of securities from registration following the termination of an offering. The Form S-3 is a registration statement used for securities offerings. This document is an amendment to a registration statement, specifically a post-effective amendment, which is a regulatory filing related to securities registration and not a financial report or earnings release. The document is short (2207 characters) and serves as a formal notice to the SEC about the status of the registration statement. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance document related to securities registration rather than a report or announcement of financial results or capital changes.
2010-03-01 English
POST EFFECTIVE AMENDMENT NO.1 TO FORM S-3
Capital/Financing Update Classification · 95% confidence The document is titled 'Post Effective Amendment No.1 to Form S-3' and is filed with the SEC. It explicitly states it is a post-effective amendment to a registration statement under the Securities Act of 1933. The content discusses removal of securities from registration and termination of the offering, which is typical for amendments related to registration statements and capital raising activities. The document is short (2205 characters) and is a formal amendment filing, not a full report or financial statement. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes, including registration statement amendments.
2010-03-01 English
POST EFFECTIVE AMENDMENT NO.1 TO FORM S-3
Capital/Financing Update Classification · 95% confidence The document is titled 'Post Effective Amendment No.1 to Form S-3' and is filed with the SEC. It discusses the removal of securities from registration and the termination of the offering under the Securities Act of 1933. Form S-3 is a registration statement used for securities offerings. The document is a post-effective amendment to a registration statement, indicating it is related to capital markets and securities registration rather than a financial report or earnings release. The content is about removing securities from registration, which aligns with capital/financing updates. The document length is short (2221 characters), but it is not merely an announcement of a report; it is an actual amendment filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2010-03-01 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.